Distortion-product otoacoustic emissions and cochlear microphonics: Relationships in patients with and without endolymphatic hydrops

Laryngoscope

Volumn 111, Issue 6, 2001, Pages 946-954

  Fetterman, Bruce L ^a,b  

^a Shea Ear Clinic   (United States)

^b NONE   (United States)

Author keywords

Cochlear microphonics; Distortion product otoacoustic emissions; Electrocochleography; Endolymphatic hydrops; Meniere's disease

Indexed keywords

ACTION POTENTIAL; AMPLITUDE MODULATION; ARTICLE; AUDIOMETRY; AUDITORY NERVOUS SYSTEM; AUDITORY THRESHOLD; CALCULATION; COCHLEA POTENTIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DISTORTION PRODUCT OTOACOUSTIC EMISSION; ELECTROCOCHLEOGRAPHY; EVOKED AUDITORY RESPONSE; FEMALE; HAIR CELL; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MENIERE DISEASE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TINNITUS; TYMPANOMETRY; VERTIGO;

EID: 0035007612     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200106000-00004     Document Type: Article

References (45)

1. Stimulated acoustic emissions from within the human auditory system
2. Hearing II: The physical basis of the action of the cochlea
3. Otoacoustic emissions: Distorted echoes of the cochlea's traveling wave
4. Outer hair cell electromotility and otoacoustic emissions
5. Evidence that inner hair cells are the major source of cochlear summating potentials
6. Distortion product emissions in humans I: Basic properties in normally hearing subjects
7. Applications of distortion-product emissions to an otological practice
8. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas
9. Otoacoustic emissions in otologic practice
10. New approaches to the evaluation of the auditory system and a current analysis of otoacoustic emissions
11. Otoacoustic emissions in human ears: Normative findings
12. A review of otoacoustic emissions
13. Otoacoustic emissions for the study of auditory function in infants and children
14. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. I: Intersubject variability and consequences on the DPOAE-gram
15. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II: Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs
16. Modeling the temporal behavior of distortion product otoacoustic emissions
17. Otoacoustic emissions from normal-hearing and hearing-impaired subjects: Distortion product responses
18. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. I: Effects of decreasing L2 below L1
19. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. II: Asymmetry in L1, L2 space
20. Toward optimizing the clinical utility of distortion product otoacoustic emission measurements
21. Frequency specificity of human distortion product otoacoustic emissions
22. Distortion product emission features and the prediction of pure tone thresholds
23. Acoustic distortion products in humans: Systematic changes in amplitude as a function of f2/f1 ratio
24. The source along the basilar membrane of the cochlear microphonic potential recorded by surface electrodes in man
25. Effects of kainic acid on the cochlear potentials and distortion product otoacoustic emissions in chinchilla
26. Excitotoxic effect of kainic acid on chicken otoacoustic emissions and cochlear potentials
27. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease
28. Diagnosis of vestibular Ménière's disease with electrocochleography
29. Diagnosis of cochlear Ménière's disease with electrocochleography
30. Transtympanic electrocochleography in Méniére's disease using clicks and tone-bursts
31. Distortion-product and transient evoked OAEs: Measurement and analysis
32. Electrocochleographic changes in relation to cochlear histopathology in experimental endolymphatic hydrops
33. Distortion product otoacoustic emissions in normal and hearing-impaired ears
34. From laboratory to clinic: A large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss
35. Nonlinear mechanics at the apex of the guinea-pig cochlea
36. The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product otoacoustic emission measurements
37. Statistical evaluation of hearing screening by distortion product otoacoustic emissions
38. Early hair cell loss in experimental hydrops
39. A human temporal bone study of changes in the basilar membrane of the apical turn in endolymphatic hydrops
40. Acoustic-distortion products: Separation of sensory from neural dysfunction in sensorineural hearing loss in human beings and rabbits
41. Comparison of compound action potential audiograms with distortion product otoacoustic emissions in experimentally induced hydrops
42. Classification of patients with Ménière's disease using otoacoustic emissions
43. Distortion product otoacoustic emissions in Ménière's disease
44. Towards understanding the limits of distortion product otoacoustic emission measurements